Safety of ciclesonide nasal spray administered with inhaled fluticasone dipropionate/salmeterol in adults with perennial allergic rhinitis (BY9010/M1-409)

Exclusion Criteria

• - Pregnancy, nursing, or plans to become pregnant or donate gametes (ova or sperm) for in vitro fertilization during the study period or for 30 days following the study period
• - Participation in any investigational drug trial within the 30 days preceding the Screening Visit
• - A known hypersensitivity to any corticosteroid or any of the excipients in the formulations
• - Use of any prohibited concomitant medications as defined by the study protocol
• - Previous participation in an intranasal ciclesonide study
• - Non-vaccinated exposure to or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit